PQ 801
801. Deputy Stephen Donnelly asked the Minister for Health if clarity will be provided to clinicians and patients regarding when daratumumab Darzalex combination therapy (details supplied) will be made available as a treatment option for persons with relapsed and or refractory myeloma. [3572/20]
Introduced
5 March 2020
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
5 March 2020
Summary
801. Deputy Stephen Donnelly asked the Minister for Health if clarity will be provided to clinicians and patients regarding when daratumumab Darzalex combination therapy (details supplied) will be made available as a treatment option for persons with relapsed and or refractory myeloma. [3572/20]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 5 March 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2020-03-05/801/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2020-03-05/pq_801